Oftentimes, the scientific method, the process, gets reversed.

They look at the conclusion that is agreeable or preferred, and then they start working backwards.

How can we prove this conclusion?

Dr. Lin Finn is a clinical research scientist and a retired infectious disease specialist.

We sat down to discuss issues she sees plaguing medical research,

from the misallocation of funds to problematic peer review processes

to major conflicts of interest.

When a pharmaceutical company gets to pour money into a program,

the curriculum is going to reflect what they want it to reflect to make it a

profitable transaction for them.

It's a return on investment.

What practical steps are needed to restore public trust in science and medicine?

Where there's transparency, there's trust.

It's really that simple.

This is American Thought Leaders, and I'm

Janja Kellick. Lynn Finn, such a pleasure to have you on American Thought Leaders.

Thank you so much, John. Thanks for having me. So what is the big issue with clinical scientific

research today?

That's a really good question.

First of all, understand that scientific publications are kind of the backbone of decision making in medicine and science as a whole.

When you hear things like evidence-based medicine, it started out with good intentions,

but it took a left turn.

...